Could CXCR7/ACKR3 help remyelination in MS?

[MSUK]

Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system.

Abstract

Current treatment modalities for the neurodegenerative disease multiple sclerosis (MS) use disease-modifying immunosuppressive compounds but do not promote repair. Although several potential targets that may induce myelin production have been identified, there has yet to be an approved therapy that promotes remyelination in the damaged central nervous system (CNS).... Read More - http://www.ms-uk.org/myelin